TCM Biotech International Corp., a biotech company, engages in the research and development of drugs for liver diseases. The company offers medical devices, such as therapy for osteoarthritis, intra-articular implant of hyaluronic acid, automated blood cell separator, absorbable adhesion barrier material, prosthetic and orthotic accessory, and pellefeel mask pressure relief pad; and pharmaceuticals, including iron supplement, therapeutic agent for urinary system, expectorant/mucolytic agent, anticancer drug, antihypertensive drug, and antidiabetic. It also provides medical detection platform for breast cancer recurrent risk detection and postoperative detection platform for liver cancer, as well as philips non-invasive positive pressure ventilation and accessories. TCM Biotech International Corp. was founded in 1998 and is headquartered in New Taipei City, Taiwan.
Frequently asked questions
What sector does TCM Biotech International Corp. (4169) operate in?
TCM Biotech International Corp. belongs to the Other sector and operates in the Biotechnology industry.
What is TCM Biotech International Corp. (4169) current stock price?
As of the latest data, TCM Biotech International Corp. stock price is NT$151.00, with a previous close of NT$151.00.
What is TCM Biotech International Corp. (4169) current market capitalization?
TCM Biotech International Corp. market cap is approximately 10.03 billion.
What is TCM Biotech International Corp. (4169) Earnings Per Share (EPS)?
The trailing EPS is NT$0.32, and the forward EPS is NT$2.34.
What is TCM Biotech International Corp. (4169) Price-to-Earnings (P/E) ratio?
TCM Biotech International Corp. current P/E ratio is 471.88, with a forward P/E of 64.53.
Does TCM Biotech International Corp. (4169) pay dividends?
Yes. TCM Biotech International Corp. pays annual dividends with an annualized yield of 0.23% and an estimated annual payout of NT$0.35 per share.
When is the next ex-dividend date for TCM Biotech International Corp. (4169)?
The next ex-dividend date is scheduled for August 28, 2026.
What is TCM Biotech International Corp. (4169) beta (volatility) score?
TCM Biotech International Corp. has a beta of 0.206, indicating lower volatility than the overall market.
